Correction to "New cancer drugs pave the way for precision medicine"

2016 ◽  
Vol 22 (9) ◽  
pp. 3
2016 ◽  
Vol 22 (7) ◽  
pp. 28-29 ◽  
Author(s):  
Allison A. Muller

2021 ◽  
Vol 23 (7) ◽  
Author(s):  
Sally Yu Shi ◽  
Xin Luo ◽  
Tracy M. Yamawaki ◽  
Chi-Ming Li ◽  
Brandon Ason ◽  
...  

Abstract Purpose of Review Cardiac fibroblast activation contributes to fibrosis, maladaptive remodeling and heart failure progression. This review summarizes the latest findings on cardiac fibroblast activation dynamics derived from single-cell transcriptomic analyses and discusses how this information may aid the development of new multispecific medicines. Recent Findings Advances in single-cell gene expression technologies have led to the discovery of distinct fibroblast subsets, some of which are more prevalent in diseased tissue and exhibit temporal changes in response to injury. In parallel to the rapid development of single-cell platforms, the advent of multispecific therapeutics is beginning to transform the biopharmaceutical landscape, paving the way for the selective targeting of diseased fibroblast subpopulations. Summary Insights gained from single-cell technologies reveal critical cardiac fibroblast subsets that play a pathogenic role in the progression of heart failure. Combined with the development of multispecific therapeutic agents that have enabled access to previously “undruggable” targets, we are entering a new era of precision medicine.


2021 ◽  
pp. 135910452110481
Author(s):  
Simon R. Wilkinson

The scientific basis for practice in child psychiatry has developed apace. And has thrown up several quandries for an accepted paradigm for good practice anchored to the diagnostic schema developed in adult psychiatry. This paper hopes to stimulate discussion about where alternative paradigms might lead us on a path to precision medicine as applied to child psychiatry.


2016 ◽  
Vol 5 (3) ◽  
pp. 46-46
Author(s):  
Fengrui Xu ◽  
Xiaodi Wang ◽  
Zefei Jiang
Keyword(s):  

Author(s):  
Zirong Chen ◽  
Peng Peng ◽  
Xiaolin Zhang ◽  
Barbara Mania-Farnell ◽  
Guifa Xi ◽  
...  

Diffuse intrinsic pontine gliomas (DIPGs) account for ~15% of pediatric brain tumors, which invariably present with poor survival regardless of treatment mode. Several seminal studies have revealed that 80% of DIPGs harbor H3K27M mutation coded by HIST1H3B, HIST1H3C and H3F3A genes. The H3K27M mutation has broad effects on gene expression and is considered a tumor driver. Determination of the effects of H3K27M on posttranslational histone modifications and gene regulations in DIPG is critical for identifying effective therapeutic targets. Advanced animal models play critical roles in translating these cutting-edge findings into clinical trial development. Here, we review current molecular research progress associated with DIPG. We also summarize DIPG animal models, highlighting novel genomic engineered mouse models (GEMMs) and innovative humanized DIPG mouse models. These models will pave the way towards personalized precision medicine for the treatment of DIPGs.


Allergy ◽  
2016 ◽  
Vol 71 (11) ◽  
pp. 1513-1525 ◽  
Author(s):  
J. Bousquet ◽  
J. M. Anto ◽  
M. Akdis ◽  
C. Auffray ◽  
T. Keil ◽  
...  

2021 ◽  
Author(s):  
Lubaina Ehsan ◽  
Marium Khan ◽  
Rasoul Sali ◽  
Alexis M. Catalano ◽  
William Adorno ◽  
...  

AbstractObjectiveDevelop a deep learning-based methodology using the foundations of systems pathology to generate highly accurate predictive tools for complex gastrointestinal diseases, using celiac disease (CD) as a prototype.DesignTo predict the severity of CD, defined by Marsh–Oberhüber classification, we used deep learning to develop a model based on histopathologic features.ResultsThe study was based on a pediatric cohort of 124 patients identified with different classes of CD severity. The model predicted CD with an overall 88.7% accuracy with the highest for Marsh IIIc (91.0%; 95% sensitivity; 91% specificity). The model identified EECs as a defining feature of children with Marsh IIIc CD and endocrinopathies which was confirmed using immunohistochemistry.ConclusionThis deep learning image analysis platform has broad applications in disease treatment, management, and prognostication and paves the way for precision medicine.SummaryWhat is already known about this subject?–Deep Learning has the potential to generate predictive models for complex gastrointestinal diseases.What are the new findings?–Our deep learning-based model used the foundations of systems pathology to generate a highly accurate predictive tool for complex gastrointestinal diseases, using a celiac disease (CD) pediatric cohort as a prototype.–The model predicated CD severity with high accuracy and identified enteroendocrine cells as a defining feature of children with severe CD and endocrinopathies.How might it impact on clinical practice in the foreseeable future?–Assessment of histopathological markers at the time of diagnosis that can predict risk of severity or complications can have broad applications in disease treatment, management, and prognostication and pave the way for precision medicine.


2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Jin-A Lee ◽  
Alex Cho ◽  
Elena N. Huang ◽  
Yiming Xu ◽  
Henry Quach ◽  
...  

AbstractThe discovery of the Cystic fibrosis (CF) gene in 1989 has paved the way for incredible progress in treating the disease such that the mean survival age of individuals living with CF is now ~58 years in Canada. Recent developments in gene targeting tools and new cell and animal models have re-ignited the search for a permanent genetic cure for all CF. In this review, we highlight some of the more recent gene therapy approaches as well as new models that will provide insight into personalized therapies for CF.


Sign in / Sign up

Export Citation Format

Share Document